Formulation of plumbagin loaded long circulating pegylated liposomes: in vivo evaluation in C57BL/6J mice bearing B16F1 melanoma

References

• Ahmad, A., Banerjee, S., Wang, Z., Kong, D., Sarkar, F.H. (2008). Plumbagin-induced apoptosis of human breast cancer cells is mediated by inactivation of NF- B and Bcl-2. J Cell Biochem. 105:1461–1471.
   PubMed Web of Science ®Google Scholar
• Allen, T.M, Cullis, P.R. (2004). Drug delivery systems: entering the mainstream. Science. 303:1818–1822.
   PubMed Web of Science ®Google Scholar
• Allen, T.M., Hansen, C. (1991). Pharmacokinetics of stealth versus conventional liposomes: effect of dose. Biochim Biophys Acta. 1068:133–141.
   PubMed Web of Science ®Google Scholar
• Aziz, M.H., Dreckschmidt, N.E., Verma, A.K. (2008). Plumbagin, a medicinal plant-derived naphthoquinone, is a novel inhibitor of the growth and invasion of hormone-refractory prostate cancer. Cancer Res. 68:9024–9032.
   PubMed Web of Science ®Google Scholar
• Chandrasekaran, B., Nagarajan, B. (1981). Metabolism of echitamine and plumbagin in rats. J Biosci. 3:395–400.
   Web of Science ®Google Scholar
• Chen, J., Ping, Q.N., Guo, J.X., Chu, X.Z., Song, M.M. (2006). Effect of phospholipid composition on characterization of liposomes containing 9-nitrocamptothecin. Drug Dev Ind Pharm. 32:719–726.
   PubMed Web of Science ®Google Scholar
• Chrai, S.S., Murari, R., Ahmad, I. (2002). Liposomes: A Review. Pharm Tech. 26:28–34.
   Google Scholar
• Crosasso, P., Ceruti, M., Brusa, P., Arpicco, S., Dosio, F., Cattel, L. (2000). Preparation, characterization and properties of sterically stabilized paclitaxel-containing liposomes. J Control Release. 63:19–30.
   PubMed Web of Science ®Google Scholar
• de Paiva, S.R., Figueiredo, M.R., Aragao, T.V., Kaplan, M.A. (2003). Antimicrobial activity in vitro of plumbagin isolated from Plumbago species. Mem Inst Oswaldo Cruz. 98:959–961.
   PubMed Web of Science ®Google Scholar
• Devi, P.U., Kamath, R., Rao, B.S. (2000). Radiosensitization of a mouse melanoma by withaferin A: in vivo studies. Indian J Exp Biol. 38:432–437.
   PubMedGoogle Scholar
• Devi, P.U., Solomon, F.E., Sharada, A.C. (1994). In vivo tumor inhibitory and radiosensitizing effects of an Indian medicinal plant, Plumbago rosea on experimental mouse tumors. Indian J Exp Biol. 32:523–528.
   PubMedGoogle Scholar
• Drummond, D.C., Meyer, O., Hong, K., Kirpotin, D.B., Papahadjopoulos, D. (1999). Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors. Pharmacol Rev. 51:691–743.
   PubMed Web of Science ®Google Scholar
• Gulati, M., Grover, M., Singh, M., Singh, S. (1998). Study of azathioprine encapsulation into liposomes. J Microencapsul. 15:485–494.
   PubMed Web of Science ®Google Scholar
• Han, H.D., Lee. A., Song, C.K., Hwang, T., Seong, H., Lee, C.O., Shin, B.C. (2006). In vivo distribution and antitumor activity of heparin-stabilized doxorubicin-loaded liposomes. Int J Pharm. 313:181–188.
   PubMed Web of Science ®Google Scholar
• Hsieh, Y.J., Lin, L.C., Tsai, T.H. (2006). Measurement and pharmacokinetic study of plumbagin in a conscious freely moving rat using liquid chromatography/tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 844:1–5.
   PubMed Web of Science ®Google Scholar
• Hsu, Y.L., Cho, C.Y., Kuo, P.L., Huang, Y.T., Lin, C.C. (2006). Plumbagin (5-hydroxy-2-methyl-1, 4-naphthoquinone) induces apoptosis and cell cycle arrest in A549 cells through p53 accumulation via c-Jun NH2-terminal kinase-mediated phosphorylation at serine 15 in vitro and in vivo. J Pharmacol Exp Ther. 318:484–494.
   PubMed Web of Science ®Google Scholar
• Immordino, M.L., Dosio, F., Cattel, L. (2006). Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential. Int J Nanomedicine. 1:297–315.
   PubMed Web of Science ®Google Scholar
• Iyer, A.K., Khaled, G., Fang, J., Maeda, H. (2006). Exploiting the enhanced permeability and retention effect for tumor targeting. Drug Discov Today. 11:812–818.
   PubMed Web of Science ®Google Scholar
• Jain, R.K. (1987). Transport of molecules across tumor vasculature. Cancer Metastasis Rev. 6:559–593.
   PubMed Web of Science ®Google Scholar
• Kaiser, N., Kimpfler, A., Massing, U., Burger, A.M., Fiebig, H.H., Brandl, M., Schubert, R. (2003). 5-Fluorouracil in vesicular phospholipid gels for anticancer treatment: entrapment and release properties. Int J Pharm. 256:123–131.
   PubMed Web of Science ®Google Scholar
• Kawiak, A., Piosik, J., Stasilojc, G., Gwizdek-Wisniewska, A., Marczak, L., Stobiecki, M., Bigda, J., Lojkowska, E. (2007). Induction of apoptosis by plumbagin through reactive oxygen species-mediated inhibition of topoisomerase II. Toxicol Appl Pharmacol. 223:267–276.
   PubMed Web of Science ®Google Scholar
• Khalil, I.A., Kogure, K., Futaki, S., Harashima, H. (2008). Octaarginine-modified liposomes: enhanced cellular uptake and controlled intracellular trafficking. Int J Pharm. 354:39–48.
   PubMed Web of Science ®Google Scholar
• Kini, D.P., Pandey, S., Shenoy, B.D., Singh, U.V., Udupa, N., Umadevi, P., Kamath, R. (1997). Antitumor and antifertility activities of plumbagin controlled release formulations. Indian J Exp Biol. 35:374–379.
   PubMedGoogle Scholar
• Kirby, C., Clarke, J., Gregoriadis, G. (1980). Effect of the cholesterol content of small unilamellar liposomes on their stability in vivo and in vitro. Biochem J. 186:591–598.
   PubMed Web of Science ®Google Scholar
• Lasic, D.D. (1996). Doxorubicin in sterically stabilized liposomes. Nature. 380:561–562.
   PubMed Web of Science ®Google Scholar
• Likhitwitayawuid, K., Kaewamatawong, R., Ruangrungsi, N., Krungkrai, J. (1998). Antimalarial naphthoquinones from Nepenthes thorelii. Planta Med. 64:237–241.
   PubMed Web of Science ®Google Scholar
• Mandala Rayabandla, S.K., Aithal, K., Anandam, A., Shavi, G., Nayanabhirama, U., Arumugam, K., Musmade, P., Bhat, K., Bola Sadashiva, S.R. (2010). Preparation, in vitro characterization, pharmacokinetic, and pharmacodynamic evaluation of chitosan-based plumbagin microspheres in mice bearing B16F1 melanoma. Drug Deliv. 17:103–113.
   PubMed Web of Science ®Google Scholar
• Massing, U., Fuxius, S. (2000). Liposomal formulations of anticancer drugs: selectivity and effectiveness. Drug Resist Updat. 3:171–177.
   PubMed Web of Science ®Google Scholar
• Miller, C.R., Bondurant, B., McLean, S.D., McGovern, K.A., O’Brien, D.F. (1998). Liposome- Cell Interactions in Vitro: Effect of Liposome Surface Charge on the Binding and Endocytosis of Conventional and Sterically Stabilized Liposomes. Biochemistry. 37:12875–12883.
   PubMed Web of Science ®Google Scholar
• Mossa, J.S., El-Feraly, F.S., Muhammad, I. (2004). Antimycobacterial constituents from Juniperus procera, Ferula communis and Plumbago zeylanica and their in vitro synergistic activity with isonicotinic acid hydrazide. Phytother Res. 18:934–937.
   PubMed Web of Science ®Google Scholar
• Nair, S., Nair, R.R., Srinivas, P., Srinivas, G., Pillai, M.R. (2008). Radiosensitizing effects of plumbagin in cervical cancer cells is through modulation of apoptotic pathway. Mol Carcinog. 47:22–33.
   PubMed Web of Science ®Google Scholar
• Naresh, R., Udupa, N., Devi, P.U., Pillai, G.K. (1996). Niosomal plumbagin with reduced toxicity and improved anticancer activity in BALB/C mice. J Pharm Pharmacol. 48:1128–1132.
   PubMed Web of Science ®Google Scholar
• Padhye, S., Dandawate, P., Yusufi, M., Ahmad, A., Sarkar, F.H. (2010). Perspectives on medicinal properties of plumbagin and its analogs. Med Res Rev. (DOI: 10.1002/med.20235, In press).
   PubMed Web of Science ®Google Scholar
• Panchagnula, R. (1998). Pharmaceutical aspects of paclitaxel. Int J Pharm. 172:1–15.
   Web of Science ®Google Scholar
• Papahadjopoulos, D., Allen, T.M., Gabizon, A., Mayhew, E., Matthay, K., Huang, S.K., Lee, K.D., Woodle, M.C., Lasic, D.D., Redemann, C. (1991). Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy. Proc Natl Acad Sci U S A. 88:11460–11464.
   PubMed Web of Science ®Google Scholar
• Powolny, A.A., Singh, S.V. (2008). Plumbagin-induced apoptosis in human prostate cancer cells is associated with modulation of cellular redox status and generation of reactive oxygen species. Pharm Res. 25:2171–2180.
   PubMed Web of Science ®Google Scholar
• Prasad, V.S., Devi, P.U., Rao, B.S., Kamath, R. (1996). Radiosensitizing effect of plumbagin on mouse melanoma cells grown in vitro. Indian J Exp Biol. 34:857–858.
   PubMedGoogle Scholar
• Sadzuka, Y., Nakade, A., Tsuruda, T., Sonobe, T. (2003). Study on the characterization of mixed polyethyleneglycol modified liposomes containing doxorubicin. J Control Release. 91:271–280.
   PubMed Web of Science ®Google Scholar
• Sahli, A., Cansell, M., Tapon-Bretaudiere, J., Letourneur, D., Jozefonvicz, J., Fischer, A.M. (1998). The stability of heparin-coated liposomes in plasma and their effect on its coagulation. Colloids Surf B Biointerfaces. 10:205–215.
   Web of Science ®Google Scholar
• Sandur, S.K., Ichikawa, H., Sethi, G., Ahn, K.S., Aggarwal, B.B. (2006). Plumbagin (5-hydroxy-2-methyl-1, 4-naphthoquinone) suppresses NF- B activation and NF- B-regulated gene products through modulation of p65 and I B kinase activation, leading to potentiation of apoptosis induced by cytokine and chemotherapeutic agents. J Biol Chem. 281:17023–17033.
   PubMed Web of Science ®Google Scholar
• Sharma, A., Sharma, U.S. (1997). Liposomes in drug delivery: progress and limitations. Int J Pharm. 154:123–140.
   Web of Science ®Google Scholar
• Singh, U.V., Udupa, N. (1997). Reduced toxicity and enhanced antitumor efficacy of betacyclodextrin plumbagin inclusion complex in mice bearing Ehrlich ascites carcinoma. Indian J Physiol Pharmacol. 41:171–175.
   PubMedGoogle Scholar
• Srinivas, P., Gopinath, G., Banerji, A., Dinakar, A., Srinivas, G. (2004). Plumbagin induces reactive oxygen species, which mediate apoptosis in human cervical cancer cells. Mol Carcinog. 40:201–211.
   PubMed Web of Science ®Google Scholar
• Talsma, H., Ozer, A.Y., Van Bloois, L., Crommelin, D.J.A. (1989). The size reduction of liposomes with a high pressure homogenizer (microfluidizer TM). Characterization of prepared dispersions and comparison with conventional methods. Drug Dev Ind Pharm. 15:197–207.
   Web of Science ®Google Scholar
• Thasni, K.A., Rakesh, S., Rojini, G., Ratheeshkumar, T., Srinivas, G., Priya, S. (2008). Estrogen-dependent cell signaling and apoptosis in BRCA1-blocked BG1 ovarian cancer cells in response to plumbagin and other chemotherapeutic agents. Ann Oncol. 19:696–705.
   PubMed Web of Science ®Google Scholar
• Tiwari, S.B., Pai, R.M., Udupa, N. (2002). Temperature sensitive liposomes of plumbagin: characterization and in vivo evaluation in mice bearing melanoma B16F1. J Drug Target. 10:585–591.
   PubMed Web of Science ®Google Scholar
• Torchilin, V.P. (2005). Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov. 4:145–160.
   PubMed Web of Science ®Google Scholar
• Vemuri, S., Rhodes, C.T. (1995). Preparation and characterization of liposomes as therapeutic delivery systems: a review. Pharm Acta Helv. 70:95–111.
   PubMedGoogle Scholar
• Vijayakumar, R., Senthilvelan, M., Ravindran, R., Devi, R.S. (2006). Plumbago zeylanica action on blood coagulation profile with and without blood volume reduction. Vascul Pharmacol. 45:86–90.
   PubMed Web of Science ®Google Scholar
• Wang, C.C.C., Chiang, Y.M., Sung, S.C., Hsu, Y.L., Chang, J.K., Kuo, P.L. (2008). Plumbagin induces cell cycle arrest and apoptosis through reactive oxygen species/c-Jun N-terminal kinase pathways in human melanoma A375. S2 cells. Cancer Lett. 259:82–98.
   PubMed Web of Science ®Google Scholar
• Xiong, X.B., Huang, Y., Lu, W., Zhang, X., Zhang, H., Nagai, T., Zhang, Q. (2005). Enhanced intracellular delivery and improved antitumor efficacy of doxorubicin by sterically stabilized liposomes modified with a synthetic RGD mimetic. J Control Release. 107:262–275.
   PubMed Web of Science ®Google Scholar
• Xu, K.H., Lu, D.P. (2010). Plumbagin induces ROS-mediated apoptosis in human promyelocytic leukemia cells in vivo. Leuk Res. 34:658–665.
   PubMed Web of Science ®Google Scholar
• Yang, T., Choi, M.K., Cui, F.D., Kim, J.S., Chung, S.J., Shim, C.K., Kim, D.D. (2007). Preparation and evaluation of paclitaxel-loaded PEGylated immunoliposome. J Control Release. 120:169–177.
   PubMed Web of Science ®Google Scholar